The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Open accessAbstract
Protein ubiquitination is a reversible reaction, in which the ubiquitin chains are deconjugated by a family of deubiquitinases (DUBs). The presence of a large number of DUBs suggests that they likely possess certain levels of substrate selectivity and functional specificity. Indeed, recent studies show that a tumor suppressor DUB, cylindromatosis (CYLD), has a predominant role in the regulation of NF-κB, a transcription factor that promotes cell survival and oncogenesis. NF-κB activation involves attachment of K63-linked ubiquitin chains to its upstream signaling factors, which is thought to facilitate protein–protein interactions in the assembly of signaling complexes. By deconjugating these K63-linked ubiquitin chains, CYLD negatively regulates NF-κB activation, which may contribute to its tumor suppressor function. CYLD also regulates diverse physiological processes, ranging from immune response and inflammation to cell cycle progression, spermatogenesis, and osteoclastogenesis. Interestingly, CYLD itself is subject to different mechanisms of regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
HADJIDAKIS, D. J., & ANDROULAKIS, I. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.035 · Cited by 1,360
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,351
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,000
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Seibenhener, M. L., Babu, J. R., Geetha, T., Wong, H. C., Krishna, N. R., & Wooten, M. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8055-8068.2004 · Cited by 710
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 608
Rodriguez, I., Ody, C., Araki, K., Garcia, I., & Vassalli, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2262 · Cited by 602
c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation
Varfolomeev, E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J., & Vucic, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800128200 · Cited by 552
Bcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527
Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
Petronczki, M., Lénárt, P., & Peters, J.-M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.014 · Cited by 485
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
de Kretser, D. M., Loveland, K. L., Meinhardt, A., Simorangkir, D., & Wreford, N. (1998) · Human Reproduction · doi:10.1093/humrep/13.suppl_1.1 · Cited by 466
Ubiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 457
Germ cell suicide: new insights into apoptosis during spermatogenesis
Print, C. G., & Loveland, K. L. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200005)22:5<423::aid-bies4>3.0.co;2-0 · Cited by 453
Li, S. S.-C. (2005) · Biochemical Journal · doi:10.1042/bj20050411 · Cited by 401
Characterization of a novel protein‐binding module — the WW domain
Sudol, M., Chen, H. I., Bougeret, C., Einbond, A., & Bork, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00550-s · Cited by 379
Abbott, D. W., Wilkins, A., Asara, J. M., & Cantley, L. C. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.032 · Cited by 374
Deubiquitylation and regulation of the immune response
Sun, S.-C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2337 · Cited by 355
Self-citationThe tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral response
Friedman, C. S., O'Donnell, M. A., Legarda‐Addison, D., Ng, A., Cárdenas, W. B., Yount, J. S., Moran, T. M., Basler, C. F., Komuro, A., Horvath, C. M., et al. (2008) · EMBO reports · doi:10.1038/embor.2008.136 · Cited by 334
New insights into NF-κB regulation and function
Sun, S.-C., & Ley, S. C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.003 · Cited by 318
Self-citationMost dysplasia in ulcerative colitis is visible at colonoscopy
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Kamm, M. A., Williams, C. B., & Forbes, A. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01710-9 · Cited by 315
Beyaert, R., Heyninck, K., & Van Huffel, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00404-4 · Cited by 301
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277
Komander, D., Lord, C. J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A., & Barford, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.018 · Cited by 276
Immunity by ubiquitylation: a reversible process of modification
Liu, Y.-C., Penninger, J., & Karin, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1731 · Cited by 257
Reiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L., Zhang, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062694 · Cited by 254
Self-citationA20 inhibits NF-κB activation by dual ubiquitin-editing functions
Heyninck, K., & Beyaert, R. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.001 · Cited by 252
ABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB
Mauro, C., Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P., & Leonardi, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601502200 · Cited by 250
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245
Conze, D. B., Wu, C.-J., Thomas, J. A., Landstrom, A., & Ashwell, J. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02098-07 · Cited by 237
Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays
Costello, C. M., Mah, N., Häsler, R., Rosenstiel, P., Waetzig, G. H., Hahn, A., Lu, T., Gurbuz, Y., Nikolaus, S., Albrecht, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020199 · Cited by 231
Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins
Wagner, S., Carpentier, I., Rogov, V, Kreike, M., Ikeda, F., Löhr, F., Wu, C.-J., Ashwell, J. D., Dötsch, V, Dikic, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211042 · Cited by 223
Regulation of Early Wave of Germ Cell Apoptosis and Spermatogenesis by Deubiquitinating Enzyme CYLD
Wright, A., Reiley, W. W., Chang, M., Jin, W., Lee, A. J., Zhang, M., & Sun, S.-C. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.09.007 · Cited by 212
Self-citationDown-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
Massoumi, R., Kuphal, S., Hellerbrand, C., Haas, B., Wild, P., Spruss, T., Pfeifer, A., Fässler, R., & Bosserhoff, A. K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082044 · Cited by 209
Yoshida, H., Jono, H., Kai, H., & Li, J.-D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509526200 · Cited by 199
Regulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C., & Sun, S.-C. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 198
Self-citationDeubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
Self-citationRegulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation
Reiley, W., Zhang, M., Wu, X., Granger, E., & Sun, S.-C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.3886-3895.2005 · Cited by 193
Self-citationShembade, N., Harhaj, N. S., Liebl, D. J., & Harhaj, E. W. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601823 · Cited by 191
Essential Role of Sequestosome 1/p62 in Regulating Accumulation of Lys63-ubiquitinated Proteins
Wooten, M. W., Geetha, T., Babu, J. R., Seibenhener, M. L., Peng, J., Cox, N., Diaz-Meco, M.-T., & Moscat, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709496200 · Cited by 182
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB
Jono, H., Lim, J. H., Chen, L.-F., Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., & Li, J.-D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406638200 · Cited by 179
Walsh, M. C., Kim, G. K., Maurizio, P. L., Molnar, E. E., & Choi, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004064 · Cited by 175
ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development
Oshima, S., Turer, E. E., Callahan, J. A., Chai, S., Advincula, R., Barrera, J., Shifrin, N., Lee, B., Yen, B., Woo, T., et al. (2009) · Nature · doi:10.1038/nature07575 · Cited by 171
Hutti, J. E., Turk, B. E., Asara, J. M., Ma, A., Cantley, L. C., & Abbott, D. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01101-07 · Cited by 168
Reduced expression of CYLD in human colon and hepatocellular carcinomas
Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Massoumi, R., & Bosserhoff, A. K. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl081 · Cited by 165
Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation
Iha, H., Péloponèse, J., Verstrepen, L., Zapart, G., Ikeda, F., Smith, C. D., Starost, M. F., Yedavalli, V. R. K., Heyninck, K., Đikić, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.5 · Cited by 155
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 152
Self-citationJenner, M. W., Leone, P., Walker, B. A., Ross, F. M., Johnson, D. C., de Castro, D. G., Chiecchio, L., Cabanas, E. D., Dagrada, G. P., Nightingale, M., et al. (2007) · Blood · doi:10.1182/blood-2007-02-075069 · Cited by 143
The tumor suppressor CYLD regulates entry into mitosis
Stegmeier, F. P., Sowa, M. E., Nalepa, G., Gygi, S. P., Harper, J. W., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703268104 · Cited by 137
HPV E6, E6AP and cervical cancer
Beaudenon, S. L., & Huibregtse, J. M. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s4 · Cited by 135
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation
Lamothe, B., Webster, W. K., Gopinathan, A., Besse, A., Campos, A. D., & Darnay, B. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.017 · Cited by 134
Regulation of IκB Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD
Zhang, M., Wu, X., Lee, A. J., Jin, W., Chang, M., Wright, A., Imaizumi, T., & Sun, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801451200 · Cited by 131
Self-citationCapturing protein tails by CAP-Gly domains
Steinmetz, M. O., & Akhmanova, A. S. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.006 · Cited by 129
The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration
Gao, J., Huo, L., Sun, X., Liu, M., Li, D., Dong, J., & Zhou, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708470200 · Cited by 128
Lamothe, B., Campos, A. D., Webster, W. K., Gopinathan, A., Hur, L., & Darnay, B. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802749200 · Cited by 123
TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD
Stokes, A. J., Wakano, C., Koblan‐Huberson, M., Adra, C. N., Fleig, A., & Turner, H. C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.12.009 · Cited by 119
Regamey, A., Hohl, D., Liu, J. W., Roger, T., Kogerman, P., Toftgård, R., & Huber, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031187 · Cited by 119
Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation
An, J., Mo, D., Liu, H., Veena, M. S., Srivatsan, E. S., Massoumi, R., & Rettig, M. B. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.007 · Cited by 115
The CAP-Gly Domain of CYLD Associates with the Proline-Rich Sequence in NEMO/IKKγ
Saito, K., Kigawa, T., Koshiba, S., Sato, K. Z., Matsuo, Y., Sakamoto, A., Takagi, T., Shirouzu, M., Yabuki, T., Nunokawa, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.07.012 · Cited by 106
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
Hövelmeyer, N., Wunderlich, F. T., Massoumi, R., Jakobsen, C. G., Song, J., Wörns, M., Merkwirth, C., Kovalenko, A., Aumailley, M., Strand, D. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070318 · Cited by 104
橋本, 毅., Mori, N., Tamesa, T., Okada, T., Kawauchi, S., Oga, A., Furuya, T., Tangoku, A., Oka, M., & Sasaki, K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800107 · Cited by 101
Genetics of skin appendage neoplasms and related syndromes
Lee, D. A., Grossman, M. E., Schneiderman, P., & Celebi, J. T. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.025577 · Cited by 92
Lim, J. H., Jono, H., Koga, T., Woo, C.-H., Ishinaga, H., Bourne, P. A., Xu, H., Ha, U., Xu, H., & Li, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001032 · Cited by 83
Tumor suppressor CYLD: negative regulation of NF-κB signaling and more
Courtois, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7465-4 · Cited by 83
CYLD mutations in familial skin appendage tumours
Saggar, S., Chernoff, K. A., Lodha, S., Horev, L., Kohl, S., Honjo, R. S., Brandt, H. R. C., Hartmann, K., & Çelebi, J. T. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056127 · Cited by 82
Wang, L., Baiocchi, R. A., Pal, S., Mosialos, G., Caligiuri, M. A., & Sif, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.7953-7965.2005 · Cited by 78
Jin, W., Reiley, W. W., Lee, A. J., Wright, A., Wu, X., Zhang, M., & Sun, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609952200 · Cited by 77
Self-citationSQSTM1 and Paget?s Disease of Bone
Layfield, R., & Hocking, L. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0041-0 · Cited by 76
Massoumi, R., & Paus, R. (2007) · BioEssays · doi:10.1002/bies.20677 · Cited by 65
Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo
Ni, C.-Y., Wu, Z., Florence, W. C., Parekh, V. V., Arrate, M. P., Pierce, S. E., Schweitzer, B. L., Kaer, L. V., Joyce, S., Miyamoto, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7107 · Cited by 55
CYLD is a crucial negative regulator of innate immune response inEscherichia colipneumonia
Lim, J. H., Ha, U., Woo, C.-H., Xu, H., & Li, J. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01204.x · Cited by 46
Mechanisms of Disease: genetics of Paget's disease of bone and related disorders
Daroszewska, A., & Ralston, S. H. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0172 · Cited by 42
Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells
Takami, Y., Nakagami, H., Morishita, R., Katsuya, T., Hayashi, H., Mori, M., Koriyama, H., Baba, Y., Yasuda, O., Rakugi, H., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070312 · Cited by 40
Cited by
Mechanisms of Deubiquitinase Specificity and Regulation
Mevissen, T. E. T., & Komander, D. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044916 · Cited by 1,027
Role of pyroptosis in inflammation and cancer
Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 699
Staudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
Vandenabeele, P., Declercq, W., Van Herreweghe, F., & Vanden Berghe, T. (2010) · Science Signaling · doi:10.1126/scisignal.3115re4 · Cited by 482
OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin
Keusekotten, K., Elliott, P. R., Glockner, L., Fiil, B. K., Damgaard, R. B., Kulathu, Y., Wauer, T., Hospenthal, M. K., Gyrd-Hansen, M., Krappmann, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.014 · Cited by 482
Metadata
- Authors
- Sun, S.-C.
- Venue
- Cell Death & Differentiation
- Published
- 2009-04-17
- Volume
- 17
- Issue
- 1
- Pages
- 25-34
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2048915877
- Cited by
- 400
- References
- 84
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.